Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 14 | $2,065,987 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 19 Mar 2024 18:44 | RVNC | Revance Therapeutics Inc | SCHILKE TOBIN | CFO | 18 Mar 2024 | Sale | 9,361 | 5.0426 | 47,204 | D |
| 05 Jul 2023 21:11 | RVNC | Revance Therapeutics Inc | SCHILKE TOBIN | CFO | 03 Jul 2023 | Sale | 1,701 | 25.04 | 42,593 | D |
| 05 Jun 2023 18:06 | RVNC | Revance Therapeutics Inc | SCHILKE TOBIN | CFO | 02 Jun 2023 | Sale | 500 | 31 | 15,500 | D |
| 05 Jun 2023 18:06 | RVNC | Revance Therapeutics Inc | SCHILKE TOBIN | CFO | 01 Jun 2023 | Sale | 2,701 | 30.57 | 82,570 | D |
| 16 May 2023 20:29 | RVNC | Revance Therapeutics Inc | SCHILKE TOBIN | CFO | 15 May 2023 | Sale | 21,401 | 34.5469 | 739,338 | D |
| 02 May 2023 16:01 | RVNC | Revance Therapeutics Inc | SCHILKE TOBIN | CFO | 01 May 2023 | Sale | 3,201 | 31.7 | 101,472 | D |
| 04 Apr 2023 16:24 | RVNC | Revance Therapeutics Inc | SCHILKE TOBIN | CFO | 03 Apr 2023 | Sale | 3,201 | 32.15 | 102,912 | D |
| 09 Mar 2023 21:46 | RVNC | Revance Therapeutics Inc | SCHILKE TOBIN | CFO | 09 Mar 2023 | Sale | 18,517 | 31.5863 | 584,884 | D |
| 02 Mar 2023 21:25 | RVNC | Revance Therapeutics Inc | SCHILKE TOBIN | CFO | 01 Mar 2023 | Sale | 3,201 | 33.5 | 107,234 | D |
| 02 Feb 2023 21:38 | RVNC | Revance Therapeutics Inc | SCHILKE TOBIN | CFO | 01 Feb 2023 | Sale | 3,201 | 34.6 | 110,755 | D |
| 23 Jan 2023 17:35 | RVNC | Revance Therapeutics Inc | SCHILKE TOBIN | CFO | 20 Jan 2023 | Sale | 1,000 | 31 | 31,000 | D |
| 10 Jan 2023 20:06 | RVNC | Revance Therapeutics Inc | SCHILKE TOBIN | CFO | 09 Jan 2023 | Sale | 1,000 | 30 | 30,000 | D |
| 10 Jan 2023 20:06 | RVNC | Revance Therapeutics Inc | SCHILKE TOBIN | CFO | 09 Jan 2023 | Sale | 1,000 | 28 | 28,000 | D |
| 10 Jan 2023 20:06 | RVNC | Revance Therapeutics Inc | SCHILKE TOBIN | CFO | 09 Jan 2023 | Sale | 1,701 | 25 | 42,525 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)